Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08BNV
|
|||
| Former ID |
DNC011430
|
|||
| Drug Name |
4,5-Dimethoxy-10H-anthracen-9-one
|
|||
| Synonyms |
4,5-dimethoxy-10H-anthracen-9-one; CHEMBL125822; 76403-03-7; AC1NRZIP; CTK2G0639; DTXSID90416070; ZINC2540909; BDBM50060856; 4,5-Dimethoxyanthracen-9(10H)-one; 9(10H)-Anthracenone, 4,5-dimethoxy-
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H14O3
|
|||
| Canonical SMILES |
COC1=CC=CC2=C1CC3=C(C2=O)C=CC=C3OC
|
|||
| InChI |
1S/C16H14O3/c1-18-14-7-3-5-10-12(14)9-13-11(16(10)17)6-4-8-15(13)19-2/h3-8H,9H2,1-2H3
|
|||
| InChIKey |
YNXDXUPTUFLKRN-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 76403-03-7
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Arachidonate 5-lipoxygenase (5-LOX) | Target Info | Inhibitor | [1] |
| BioCyc | Aspirin-triggered lipoxin biosynthesis | |||
| Resolvin D biosynthesis | ||||
| Leukotriene biosynthesis | ||||
| Lipoxin biosynthesis | ||||
| Aspirin triggered resolvin D biosynthesis | ||||
| Aspirin triggered resolvin E biosynthesis | ||||
| KEGG Pathway | Arachidonic acid metabolism | |||
| Metabolic pathways | ||||
| Serotonergic synapse | ||||
| Ovarian steroidogenesis | ||||
| Toxoplasmosis | ||||
| NetPath Pathway | IL4 Signaling Pathway | |||
| Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
| WikiPathways | Vitamin D Receptor Pathway | |||
| Arachidonic acid metabolism | ||||
| Eicosanoid Synthesis | ||||
| Selenium Micronutrient Network | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity. J Med Chem. 1997 Nov 7;40(23):3773-80. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.